Vanda Pharmaceuticals (VNDA) Stock: Buy, Sell, or Hold?
$4.08
-0.01 (-0.24%)
▼
5d:
+8.8%
30d:
-10.13%
90d:
-21.39%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (87%)
Quality Score
55/100
Position
FAIR
30-Day Fair Range
$3.86 – $4.43
Position: FAIR
Forward P/E & Valuation
-5.5x
Next 12M consensus est.
Wall Street Target
$11.50
+181.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.57 / $4.64
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: VNDA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When VNDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VNDA is currently trading at $4.08, which is considered fair relative to its 30-day fair value range of $3.86 to $4.43.
Technical Outlook: Technically, VNDA is in a strong downtrend. Immediate support is located at $3.56, while resistance sits at $4.64.
Market Sentiment: VNDA scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+181.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VNDA is in a strong downtrend. Immediate support is located at $3.56, while resistance sits at $4.64.
Market Sentiment: VNDA scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.50 (+181.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.86 -
$4.43
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
Trading Range & Key Levels
30-Day Trading Range
$3.86 -
$4.43
Current vs Trading Range
FAIR
Support Level
$3.57
Resistance Level
$4.64
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 181.9% below Wall St target ($11.50)
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-5.53
Wall Street Target
$11.50
(+181.9%)
Revenue Growth (YoY)
24.1%
Earnings Growth (YoY)
-95.9%
Profit Margin
-119.9%
Share VNDA Analysis
Share this live VNDA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VNDA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is currently seeing bullish sentiment towards $VNDA with one user expressing optimism.
Key Retail Themes:
Positivity towards the company
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 11:02 PM ET
Data refreshes hourly during market hours. Next update: 12:02 AM
Data refreshes hourly during market hours. Next update: 12:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 49 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 62 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VNDA Research Pages
